Sort
10,766 grants matching “checkpoint inhibitor”
Roles of Lig3 and XRCC1 Genes in Genome Stability
$152,604Alan E Tomkinson · University Of Maryland Baltimore · R01 · FY2011 · ES
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$152,499Glenn Edward Simmons · Cornell University · K01 · FY2023 · CA
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$152,499Glenn Edward Simmons · Cornell University · K01 · FY2022 · CA
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$152,499Glenn Edward Simmons · Cornell University · K01 · FY2025 · CA
DEATH AGONIST, BID, AND DEVELOPMENT AND NEOPLASIA
$152,496University Of Pittsburgh At Pittsburgh · K01 · FY2000 · CA
DEATH AGONIST, BID, AND DEVELOPMENT AND NEOPLASIA
$152,496University Of Pittsburgh At Pittsburgh · K01 · FY2001 · CA
Characterization of the DNA replication protein Sid2p
$152,143Swarthmore College · R15 · FY2002 · GM
A Chemical Biology Approach for Discovery of HDAC Inhibitors
$151,965Taro Amagata · San Francisco State University · SC2 · FY2011 · GM
A Chemical Biology Approach for Discovery of HDAC Inhibitors
$151,965Taro Amagata · San Francisco State University · SC2 · FY2012 · GM
G2 Role For Cdk2 in Human Cells
$151,610Gregory H. Enders · University Of Pennsylvania · R01 · FY2006 · GM
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2017 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2018 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2019 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2016 · CA
Predicting and profiling long-term survival after immune checkpoint inhibition
$151,200Douglas B Johnson · Vanderbilt University Medical Center · K23 · FY2020 · CA
A Novel Pathway Involving ATM, PP1 and I-2
$151,069Bo Xu · Methodist Hospital Research Institute · R01 · FY2010 · ES
Repurposing drugs and finding new therapeutic targets for cutaneous malignancies
$150,823Natasha Hill · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
NEUROPATHOLOGY/TISSUE BANK CORE
$150,594Claudia Katharina Petritsch · Stanford University · U54 · FY2022 · CA
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes
$150,175Kay Huebner · Ohio State University · R01 · FY2013 · CA
Defining the functional role of T-cells in Autosomal Dominant Polycystic Kidney Disease pathology
$150,039Katharina Hopp · University Of Colorado Denver · K01 · FY2018 · DK
Biology of the Hormonal Regulation of Cancer and Immuno Oncology Outcomes Research Proposal.
$150,000Lisa M Coussens · Oregon Health & Science University · P30 · FY2025 · CA
BMT in Solid Tumors
$149,592Kenneth R Cooke · Johns Hopkins University · P01 · FY2023 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$149,521Lily Yang · Emory University · R01 · FY2024 · CA
Dissecting mechanisms of immunotherapy resistance in melanoma patients
$149,255Benjamin Izar · Columbia University Health Sciences · K08 · FY2019 · CA
Molecular Interactions of APOBEC3 Enzymes with the Cancer Genome
$148,742Abby Margaret Green · Washington University · K08 · FY2019 · CA